{
    "nctId": "NCT02923700",
    "officialTitle": "Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial",
    "inclusionCriteria": "1. patients affected by mono-lateral symptomatic knee articular degenerative pathology with history of chronic (for at least 4 months) pain or swelling;\n2. imaging findings of degenerative changes of the joint (osteoarthritis or chondropathy with Kellgren Lawrence Score from 0 to 3 at X-ray evaluation).\n* Must have minimum age of 18 Years\n* Must have maximum age of 80 Years",
    "exclusionCriteria": "* age \\> 80 years;\n* Kellgren-Lawrence score at X-ray evaluation \\> 3;\n* major axial deviation (varus \\>5\u00b0 , valgus \\> 5\u00b0),\n* systemic disorders such as diabetes, rheumatoid arthritis, haematological diseases (coagulopathy), severe cardiovascular diseases, infections, immunodepression;\n* patients in therapy with anticoagulants or antiaggregants;\n* use of NSAIDs in the 5 days before blood donation;\n* patients with Hb values \\< 11 g/dl and platelet values \\< 150,000/mmc."
}